{"version":"1.0","type":"link","title":"Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trial.","author_name":"Ju H 외","author_url":"https://prs-insight.online/author/Ju%20H","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168776","thumbnail_width":1200,"thumbnail_height":630}